Nevertheless, Li et al. demonstrated that a concomitant elevation of AFP and CA 19-9 was found only in approximately 15% of cHCC-CCA patients, suggesting a limited sensitivity of these blood tests [24]. This evidence concerns the gene AFP and cholangiocarcinoma.